The US Food and Drug Administration says a recall by Medtronic PLC of its Angiographic Guidewire Component devices is high-risk class I.
The company’s vascular division recalled nearly 55,000 of the guidewires on 4 May; they were distributed from November 2007 through...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?